AdvaMed cautions FDA against unnecessary changes to 510(k) process

06/13/2013 | MassDevice.com (Boston)

An FDA proposal to increase its oversight of 510(k) medical device modifications has received pushback from AdvaMed, which warned the new rules could lead to a greater number of 510(k) submissions without doing much to benefit patient safety. The current process has proven to be successful in maintaining timely review and patient safety, and "it is unclear that there is a real problem that needs to be solved," AdvaMed said in a white paper. The FDA is scheduled to hold a public meeting today to discuss possible changes.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park